Abstract
Although the Child/Adolescent Anxiety Multimodal Study (CAMS) trial demonstrated the efficacy of medication, CBT, and combined treatments for child anxiety, remission is often difficult to achieve in the short term, and longer-term relapse is relatively common. The objective of this presentation is to review factors impacting treatment response for anxiety and to demonstrate how they can be used to inform clinical decision making that leads to more robust therapeutic outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
